Biogen Inc (BIIB)

Current ratio

		Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020
Total current assets	US$ in thousands	7,456,800	6,830,500	7,108,500	6,756,200	6,859,300	8,454,100	10,431,700	9,762,500	9,791,200	9,765,800	9,740,900	7,915,900	7,856,500	7,162,300	7,183,700	6,719,500	6,887,100	7,843,100	8,493,800	8,007,200
Total current liabilities	US$ in thousands	5,528,800	5,425,000	3,108,200	3,222,800	3,434,300	5,022,300	3,186,500	3,014,900	3,272,800	3,926,400	5,018,000	3,946,600	4,298,200	4,211,600	3,347,200	3,165,800	3,742,200	3,804,000	3,447,100	4,638,600
Current ratio		1.35	1.26	2.29	2.10	2.00	1.68	3.27	3.24	2.99	2.49	1.94	2.01	1.83	1.70	2.15	2.12	1.84	2.06	2.46	1.73

December 31, 2024 calculation

Current ratio = Total current assets ÷ Total current liabilities
= $7,456,800K ÷ $5,528,800K
= 1.35

Biogen Inc's current ratio has displayed fluctuations over the reported periods. The ratio indicates the company's ability to cover its short-term obligations with its current assets. From March 31, 2020, to June 30, 2024, the current ratio ranged from a low of 1.26 to a high of 3.27. Notably, the ratio saw significant improvement from the first quarter of 2020 to the second quarter of 2023, peaking at 3.27, suggesting a strong ability to meet short-term liabilities. However, there was a notable decline in the current ratio in the following quarter, dropping to 1.68. The ratio recovered slightly in the subsequent quarters but remained below the highs seen earlier. It is important to note that a higher current ratio generally indicates better liquidity and financial health, ensuring the company can meet its near-term obligations.